Lifelong persistent EBV infection of rabbits with EBER1-positive lymphocyte infiltration and mild sublethal hemophagocytosis

Virus Research

Volumn 153, Issue 1, 2010, Pages 172-178

  Kanai, Kyosuke ^a,d,e   Takashima, Kazuaki ^a,b   Okuno, Keisuke ^a   Kato, Kaoru ^a,c   Sano, Hitoshi ^a   Kuwamoto, Satoshi ^a   Higaki, Hiromi ^a   Nagata, Keiko ^a   Sugihara, Hirotsugu ^a   Kato, Masako ^a   Murakami, Ichiro ^a   Hayashi, Kazuhiko ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Animal Clinical Research Foundation   (Japan)

^c Kato Animal Hospital   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Epstein Barr virus (EBV); Infection model animal; Persistent EBV infection

Indexed keywords

VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOPSY; CONTROLLED STUDY; ECHOGRAPHY; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RABBIT; SPLEEN;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; LYMPHOCYTES; RABBITS; RNA, VIRAL; SPLEEN; VIRAL MATRIX PROTEINS;

ANIMALIA; HUMAN HERPESVIRUS 4; ORYCTOLAGUS CUNICULUS;

EID: 77956230593     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.07.026     Document Type: Article

References (30)

1. Aozasa K. Pyothorax-associated lymphoma. Int. J. Hematol. 1996, 65(1):9-16.
2. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S., Barrell B.G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984, 310(5974):207-211.
3. Chang K.L., Chen Y.Y., Shibata D., Weiss L.M. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1992, 1(4):246-255.
4. -/- mice as a model for Epstein-Barr virus infection. Am. J. Pathol. 2008, 173(5):1369-1378.
5. Cohen J.I. Epstein-Barr virus infection. N. Engl. J. Med. 2000, 343(7):481-492.
6. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1(7335):702-703.
7. Epstein M.A., zur Hausen H., Ball G., Rabin H. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). III. Serological and biochemical findings in an animal with reticuloproliferative disease. Int. J. Cancer 1975, 15(1):17-22.
8. Hayashi K., Jin Z., Onoda S., Joko H., Teramoto N., Ohara N., Oda W., Tanaka T., Liu Y.X., Koirala T.R., Oka T., Kondo E., Yoshino T., Takahashi K., Akagi T. Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS. Am. J. Pathol. 2003, 162(5):1721-1736.
9. Hayashi K., Joko H., Koirala T.R., Onoda S., Jin Z.S., Munemasa M., Ohara N., Oda W., Tanaka T., Oka T., Kondo E., Yoshino T., Takahashi K., Yamada M., Akagi T. Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease. Histol. Histopathol. 2003, 18(4):1155-1168.
10. Hayashi K., Ohara N., Teramoto N., Onoda S., Chen H.L., Oka T., Kondo E., Yoshino T., Takahashi K., Yates J., Akagi T. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am. J. Pathol. 2001, 158(4):1533-1542.
11. Hsieh W.C., Chang Y., Hsu M.C., Lan B.S., Hsiao G.C., Chuang H.C., Su I.J. Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome. Am. J. Pathol. 2007, 170(5):1629-1639.
12. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit. Rev. Oncol. Hematol. 2002, 44(3):259-272.
13. Isaacson P., Wright D.H. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983, 52(8):1410-1416.
14. Johannessen I., Crawford D.H. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev. Med. Virol. 1999, 9(4):263-277.
15. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?. Rev. Med. Virol. 2006, 16(4):251-261.
16. Kimura H., Ito Y., Suzuki R., Nishiyama Y. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev. Med. Virol. 2008, 18(5):305-319.
17. Kimura H., Morita M., Yabuta Y., Kuzushima K., Kato K., Kojima S., Matsuyama T., Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 1999, 37(1):132-136.
18. Melkus M.W., Estes J.D., Padgett-Thomas A., Gatlin J., Denton P.W., Othieno F.A., Wege A.K., Haase A.T., Garcia J.V. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006, 12(11):1316-1322.
19. Mosier D.E., Gulizia R.J., Baird S.M., Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335(6187):256-259.
20. Okuno K., Takashima K., Kanai K., Ohashi M., Hyuga R., Sugihara H., Kuwamoto S., Kato M., Sano H., Sairenji T., Kanzaki S., Hayashi K. Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans. J. Med. Virol. 2010, 82(6):977-986.
21. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields Virology 1996, vol. 2:2397-2446. Lippincott-Raven Publishers, Philadelphia. 3rd ed.
22. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields Virology 2007, vol. 2:2655-2700. Lippincott Williams & Wilkins, a Wolters Kluwer Business, Philadelphia. 5th ed.
23. Rivailler P, Carville A., Kaur A., Rao P., Quink C., Kutok J.L., Westmoreland S., Klumpp S., Simon M., Aster J.C., Wang F. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 2004, 104(5):1482-1489.
24. Shope T., Dechairo D., Miller G. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc. Natl. Acad. Sci. U.S.A. 1973, 70(9):2487-2491.
25. Straus S.E. The chronic mononucleosis syndrome. J. Infect. Dis. 1988, 157(3):405-412.
26. Straus S.E., Cohen J.I., Tosato G., Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann. Intern. Med. 1993, 118(1):45-58.
27. Sugimoto M., Tahara H., Ide T., Furuichi Y. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 2004, 64(10):3361-3364.
28. Takashima K., Ohashi M., Kitamura Y., Ando K., Nagashima K., Sugihara H., Okuno K., Sairenji T., Hayashi K. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis. J. Med. Virol. 2008, 80(3):455-466.
29. Williams H., Crawford D.H. Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood 2006, 107(3):862-869.
30. Yajima M., Imadome K., Nakagawa A., Watanabe S., Terashima K., Nakamura H., Ito M., Shimizu N., Honda M., Yamamoto N., Fujiwara S. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 2008, 198(5):673-682.